New research highlights how the developing human brain may eliminate neurons carrying chromosomal abnormalities around the time of birth. Other reports examine the feasibility of a space-based solar geoengineering system, warning signs of suspicious journal activity, why dengue can be more severe after reinfection, and the need for a broader definition of immune health.
Neurons with chromosomal abnormalities disappear before birth
Around the time of birth, the developing human brain appears to eliminate vast numbers of neurons carrying mutations. Researchers found that more than one-quarter of the neurons sampled from human fetuses had some form of chromosomal abnormality. That proportion fell to 6% in the brains of newborn babies.
The findings point to a previously unidentified mechanism that regulates how many neurons a person has and determines which fetal neurons survive, said pediatric neurogeneticist and study co-author Diane Hsiao.
Nature | 5 minute read
Reference: Nature paper
A possible planetary sunshade
A new report suggests that it could be possible to launch a fleet of satellites that reflect sunlight away from Earth and lower global temperatures within 20 to 40 years. The timetable for such a “planetary sunshade” would depend on how quickly heavy-lift rockets capable of transporting materials into deep space are developed.
Space systems engineer Chantal Cappelletti says that many people consider the idea “just a pipe dream.” However, falling space-launch costs have made space-based solar geoengineering more realistic.
Nature | 6 minute read
Reference: Planetary Sunshade Institute report
Three warning signs of suspicious journal activity
Researchers have identified three signals that a journal might warrant investigation for suspicious publishing activity:
- Its publication output doubles in a single year.
- At least 70% of its published articles come from one country.
- At least 15% of its articles are flagged by the free online tool Questionable Paper Screener.
Using journal titles from the OpenAlex database, the team identified 3,753 journals that met at least one of these criteria. The signals can help identify journals for further investigation, but they do not prove that a journal is problematic, the study authors said.
Nature | 5 minute read
Reference: Zenodo preprint (not peer reviewed)
Why a second dengue infection can be more severe
Results from a clinical trial in which volunteers were intentionally infected with a weakened strain of dengue virus suggest why the disease can be more severe after a second infection. This effect has complicated efforts to develop a dengue vaccine.
People who had previously been infected with dengue tended to have higher viral loads and stronger hyperinflammatory signals during their second infection than people who had never encountered the virus. Those with the highest viral loads had fewer antibodies capable of fighting the infection, and their antibodies were less effective.
Nature | 4 minute read
Reference: Science Translational Medicine paper
Features and impressions
Defining immune health
To better understand how people respond to specific treatments, a group of medical researchers argues that scientists should develop a comprehensive characterization of “immunity” — or immune health — across cells, tissues, organs and molecular interactions.
The first step, they say, is to identify measurements that indicate weakened or diminished immune function. “Immune health could become a routine aspect of medicine if scientists can figure out which measurements matter, validate them in diverse populations, and establish when acting on those measurements improves disease outcomes,” the research group wrote.
Nature | 11 minute read
How lived experience can shape scientific research
Formerly homeless ecologist Sage Raymond studies interactions between urban wildlife and people living in shelters. A reviewer of an earlier draft of her work wrote that Raymond and her colleagues appeared “naive about homelessness.”
“That assumption shocked me; it implied that someone with my background did not belong in academia,” Raymond wrote. She developed skills that enabled her research, but says that “many of the life experiences that bring diversity to science are invisible,” leaving room for harmful assumptions.
Quote of the day
Ashley Krupiel took part in a clinical trial of galetosumab, a treatment for fibrodysplasia ossificans progressiva (FOP). This extremely rare disease gradually turns connective tissue into bone.
Although the drug cannot reverse the progression of Krupiel’s disease, her participation could provide researchers with valuable safety and efficacy data. (New York Times | 6 min read)
Which animal could you beat in a race?
Today, I’m thinking about an important question: which animal could win in a running race? The answer is more complicated than you might think, according to a researcher.
Many animals have higher top speeds than the average human, but they accelerate more slowly. Distance also matters: faster animals might not have the stamina to reach the finish line.
Unfortunately, I lack both speed and stamina, so my chances of winning are generally low.
Please let us know which animals you think would be the best competitors, along with your feedback on this newsletter, at [email protected].
Thank you for reading,
Jacob Smith, Associate Editor, Nature Briefing
- Nature Briefing: Careers — insights, advice and award-winning journalism to help you optimize your work life.
- Nature Briefing: Microbiology — coverage of microorganisms, the most abundant life forms on Earth, and their roles in health, the environment and our food system.
- Nature Briefing: The Anthropocene — climate change, biodiversity, sustainability and geoengineering.
- Nature Briefing: AI and Robotics — 100% written by humans, of course.
- Nature Briefing: Cancer — a weekly newsletter written with cancer researchers in mind.
- Nature Briefing: Translational Research — biotechnology, drug discovery and pharmaceuticals.
Source: www.nature.com


